Biomotion Sciences Ordinary Shares (SLXN) — Net Asset Momentum
Biomotion Sciences Ordinary Shares (SLXN) recorded a net asset momentum of 165.3% as of December 2025, with net assets of $2.60 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Biomotion Sciences Ordinary Shares (SLXN) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Biomotion Sciences Ordinary Shares Net Asset Momentum (2020–2025)
This chart tracks Biomotion Sciences Ordinary Shares's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +165.3%, with net assets of $2.60 Million USD as of December 2025. Read debt load of Biomotion Sciences Ordinary Shares for a breakdown of total debt and financial obligations.
Annual Net Asset History for Biomotion Sciences Ordinary Shares (2020–2025)
The table below shows the complete annual net asset history for Biomotion Sciences Ordinary Shares from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see SLXN market cap overview.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $2.60 Million | $7.21 Million | $4.61 Million | ▲ +165.3% |
| 2024 | $-3.99 Million | $2.86 Million | $6.85 Million | ▲ +66.9% |
| 2023 | $-12.06 Million | $5.26 Million | $17.31 Million | ▼ -70.3% |
| 2022 | $-7.08 Million | $9.33 Million | $16.41 Million | ▼ -106.2% |
| 2021 | $114.91 Million | $115.41 Million | $508.92K | ▲ +67694.9% |
| 2020 | $-169.99K | $129.40K | $299.39K | — |